Health Care

The Future of Medicine is Now: Why one orthopedic surgeon is embracing telehealth

 
 
Dr. Richard Berger, M.D., a world-renowned orthopedic surgeon at Midwest Orthopedics at Rush and assistant professor at Rush University Medical Center, Chicago joins eHealth Radio and the Orthopedic & Tele-medicine Channels. The pioneer of a minimally invasive technique, Dr. Berger was the first in the world to perform outpatient hip and knee replacement surgery and has done over 12,000 surgeries -- more than any other surgeon.
Listen to interview with host Eric Michaels and guest Dr. Richard Berger discuss the following:
Can you tell us about your background? What got you started in orthopedics? What makes your approach to joint replacement unique? Who are the patients that you are normally seeing?
During the pandemic, many physicians quickly pivoted to tele-health to continue seeing patients. Can you discuss this shift how it has affected your work with patients?
Would you say that tele-health has allowed you to interact with patients in ways that you could not previously?
How has tele-health led to greater convenience for your patients?
Do you think that embracing tele-health during the pandemic led to greater success for you and your patients? Is Tele-health here to stay?
Richard Berger, M.D., is a world-renowned orthopedic surgeon at Midwest Orthopedics at Rush and assistant professor at Rush University Medical Center, Chicago. He pioneered a minimally invasive hip and knee replacement that allows for a quicker and less painful recovery than traditional joint replacement. He also was the first in the world to perform outpatient hip and knee replacement surgery and has done over 12,000 surgeries -- more than any other surgeon. Patients come from all the world to have surgery from Dr. Berger, and they include elite athletes, politicians and celebrities.
 
Website: https://outpatienthipandknee.com
Social Media Links: Facebook: facebook.com/DrRichardBerger  Instagram: instagram.com/drrichardberger  Twitter: @DrRichBerger 

Reinventing Financial Navigation

 
 
Srulik Dvorsky, the CEO and Co-founder of TailorMed, a leading financial navigation technology company that helps patients remove financial barriers to care joins eHealth Radio and the Health News Channel.
Listen to interview with host Eric Michaels and guest Srulik Dvorsky discuss the following:
What is TailorMed and what was the driving force behind founding the company?
What unique need is TailorMed solving for patients and for health systems?
What is the importance of price transparency in healthcare for the patient? For a health system?
How is TailorMed improving patient experience?
What is TailorMed doing to fight inequities in healthcare and level the playing field?
How has the patient's financial burden impacted providers, particularly at a time when COVID-19 has led to a drop in patient volume?
Srulik Dvorsky is the co-founder and CEO of TailorMed, the leading financial navigation technology company that helps patients and healthcare providers remove financial barriers to care. After serving as the primary caretaker for several family members following a cancer diagnosis, he started TailorMed with a personal mission to leverage technology to remove barriers to care. He brings to the company more than a decade of experience in the medical device industry.
 
Website: https://tailormed.co
Social Media Links: Facebook: facebook.com/TailorMed.co   Instagram: instagram.com/tailormed.co

Servicon, elevating the cleaning industry by provide healthy environments

 
 
Laurie Sewell, President and CEO of Servicon, a leading environmental, custodial and maintenance company located in Southern California joins eHealth Radio and the Health News Channel.
Listen to interview with host Eric Michaels and guest Laurie Sewell discuss the following:
Tell us about Servicon and its mission.
How has Servicon as an EVS leader helped in the fight against COVID?
How does Servicon prepare its custodian technicians to do their jobs optimally and in the best interests of society?
How is Servicon a critical partner in healthcare?
How does Servicon help hospitals?
What are Servicon’s top priorities for the next 12 months?
Laurie Sewell is President and CEO of Servicon, a provider of exemplary custodial, environmental, and maintenance services for complex facilities.
Servicon partners with Fortune 500 companies in the healthcare, aerospace, manufacturing, commercial real estate, municipal and entertainment industries. Their purpose is to elevate the industry and provide healthy environments for people to thrive.
Considered a disrupter in an industry steeped in tradition, Sewell is shifting the focus from conventional concepts of custodial services to those that are driving wellness, sustainability, new analytics and employee engagement with innovative technologies and training.
At the helm of a diverse workforce of over 1,800 employees, Sewell is passionate about the concept that profit should be achieved through the focus on talent development at all levels of an organization.
Sewell has held positions on international, advisory and editorial boards in her industry. She was also a stakeholder in the development of the GS-42 Green Seal standard. She holds a MA in Organizational Behavior and operates her business under the belief that “it is always about the people.”
Servicon’s five decades of success is due to the alignment of their unique corporate culture with their strategy. They have succeeded in doing well by doing the right thing for all people involved.
 
 
Website: www.servicon.com
Social Media Links: Facebook: facebook.com/ServiconSystemsCAJanitorial Twitter: twitter.com/Servicon

Dr. Stephen Harrison Discusses Clinical Importance of FibroScan Technology

 
 
Dr. Stephen A. Harrison, gastroenterologist and hepatologist, joins eHealth Radio and the Health News & Technology Channels to discuss the role FibroScan technology has played in the management of patients with liver disease.
Listen to interview with host Eric Michaels and guest Dr. Stephen A. Harrison discuss the following:
Please share with us the ongoing need for assessing liver stiffness and fat as part of a liver health assessment – and why the detection of fatty liver disease remains such a pressing challenge for Americans, especially during the COVID-19 pandemic.

How does FibroScan tie into your clinical workflow? How might other clinicians be able to utilize it?

Tell us about the successes you are seeing as a result of the FibroScan FAST score implementation and the research you’ve gathered from it.
What work is being done to improve any previous high screen failure rates? Has there been any improvement since late phase clinical trials?

Do you have any patient stories that you could share with us about the success of monitoring liver stiffness and fat with FibroScan?

What will your focus be on continuing to bring awareness of NAFLD diagnosis and treatment in a post-pandemic world?

Where do you see this research going in terms of the management of liver disease and improving outcomes for patients?
Dr. Stephen A. Harrison, M.D., FACP, FAASLD, retired COL, USA, MC, gastroenterologist and hepatologist, medical director of Pinnacle Clinical Research, and visiting professor of Hepatology, University of Oxford.
About Echosens
Echosens, the developer of FibroScan®, is an innovative high-technology company offering a full range of products and services supporting physicians in their assessment and management of patients with chronic liver diseases. FibroScan is supported by over 2,500 peer-reviewed publications and examinations are covered by Medicare, Medicaid and many insurance plans.
Website: https://echosens.com
Social Media Links: Facebook: facebook.com/fibroscan.echosens  Linkedin: linkedin.com/company/echosens  Youtube: youtube.com/user/EchosensTV

Bastille Delivers Zone Detection for Healthcare Sector

 
 
Bob Baxley, CTO at Bastille Networks a company that delivers enterprise threat detection through software-defined radio joins eHealth Radio and the Technology Channel.
Listen to interview with host Eric Michaels and guest Bob Baxley discuss the following:
Can you provide our listeners a background on Bastille and why the company was created?
What are some of the pain points in radio frequency that Bastille is addressing?
How will radio frequency’s complexity in the workplace change as workers return based on the devices they bring and the devices that they may be asked to wear?
What are the benefits of using Bastille's technology for zone detection to mitigate the unforeseen new threats from other contact tracing technologies?
What are some steps that the healthcare industry can improve to protect facilities and patient data from adversaries?
For more than a decade, Dr. Bob Baxley has been a technology leader in implementing machine learning algorithms for software defined and cognitive radios. At Bastille, Bob serves as Chief Technology Officer where he leads the development of systems to sift through massive amounts of radio frequency data to protect enterprises from radio threats.
Prior to joining Bastille, Bob was the Director of the Software Defined Radio Lab at Georgia Tech, where he led basic and applied research projects for organizations including NSF, ONR, Army, DoD, Air Force and DARPA. He has published more than 100 peer-reviewed papers and patents, is the receipt of various research awards, and is a Senior Member of the IEEE. He also led the GTRI team that competed in the DARPA Spectrum Challenge and placed second out of 90 teams.
 
 
Website: www.bastille.net
Social Media Links: Twitter: twitter.com/bastillenet  Linkedin: linkedin.com/company/bastille-networks

Leveraging Precision Medicine to Improve Lives, Reduce Healthcare Costs, and Simplify Decision-making

 
 
Scott Megill, President and CEO at Coriell Life Sciences, a precision medicine company using genetic science and research to improve lives, reduce healthcare costs, and simplify decision-making for its customers joins eHealth Radio and the Health News Channel.
Listen to interview with host Eric Michaels & guest Scott Megill discuss the following:
Who is Coriell Life Sciences?
How does Coriell Life Sciences partner with the healthcare community to deliver paths to better health?
What makes Coriell Life Sciences unique?
How can individuals benefit from participating in Coriell Life Sciences’ medication safety program?
What’s the biggest opportunity for the healthcare ecosystem when it comes to personalized medicine?
Medications don’t work for everyone. Nearly one-third of U.S. adults take five or more prescription drugs and, even when taken correctly, they can be dangerous for many. Payers, providers, and patients bear the financial and physical burdens of inappropriate, ineffective drugs. Each year medication errors lead to 128,000 deaths and the costs of medication-associated errors exceed $40 billion in the U.S. alone. The cost of getting medications wrong reverberates through the healthcare service model and echoes back as wasted resources, time, and poor health.
For hundreds of medications, successful treatment is directly related to an individual’s DNA. Natural variation in our genetic code can cause the same drug to produce different effects on different people. The science of pharmacogenomics (PGx) can now assist in assessing how each person will respond to medications, however, DNA testing alone is not sufficient. That’s why Coriell Life Sciences (CLS) leverages advanced, proprietary technology to bridge the gap between genetic knowledge and clinical application. Building on six decades of research, CLS developed a cutting-edge bioinformatics solution that interprets pharmacogenomic laboratory results and couples them with traditional medication management risk factors to deliver a dynamic regimen modeling tool.
Driving innovation in precision medicine, CLS unlocks the power of genetic science to provide actionable insights for employers, payers, healthcare providers, physicians, pharmacists, laboratories, and patients, that enable more effective and efficient care.
Backed by rigorous scientific methodology, Corigen™, CLS’ population-scale medication safety program, is the most comprehensive medication safety solution on the market. This novel solution is powered by CLS’s real-time medication decision support modeling tool, GeneDose LIVE. This unique system provides physicians with updated medication risk information for their patients’ current medication regimen and offers alternatives for safer therapy, all in real-time. GeneDose LIVE also provides risk analysis of non-genetic factors such as lifestyle, drug interactions, age-related risks, and other concerns, along with a personalized medication action plan (MAP) that reveals which medications are best suited for an individual.
By matching people with the right medications, CLS enables patients to benefit from fewer hospitalizations, less unneeded testing, and reduced doctor’s visits, ultimately decreasing healthcare costs. Most importantly, CLS reduces costly trial-and-error experimentation and speeds patients’ return to good health.
Recognized as a leader in precision medicine and health innovation—including IBM’s Entrepreneur of the Year—CLS leverages its influence to advocate for the advancement of precision medicine. The organization is highly active with the American Society of Pharmacovigilance, the Personalized Medicine Coalition, a signing member of the Get the Medications Right Institute, and passionate about educating stakeholder groups through the Population Health Colloquium, Health Action Council, Employer Health Innovation Roundtable, and various other platforms.
As CLS collaborates with major healthcare providers to empower the most precise medical care, the organization is continually pushing the boundaries of what’s possible—serving as the gold standard in knowledge and understanding of pharmacogenomics.
 
 
Website: https://coriell.com
Linkedin Links: Company LinkedIn: linkedin.com/company/corielllife Personal LinkedIn: linkedin.com/in/scottmegill

How the pandemic has accelerated innovation in healthcare: A conversation with Karly Rowe from Experian Health

 
 
Karly Rowe, Vice President of Patient Access, Identity & Care Management Product for Experian Health that works with more than 3,200 hospitals and 10,000 other healthcare organizations representing 500,000 plus providers to provide data-driven solutions that support revenue cycle management, identity management, patient engagement and care management joins eHealth Radio and the Health Care and Health News Channels.
Listen to interview with host Eric Michaels and guest Karly Rowe discuss the following:
Can you tell us about Experian Health and your role within the company?
Any discussion of healthcare today is framed by the COVID-19 pandemic. From your business, your line of sight, what has the pandemic put in the spotlight?
In the early days of the pandemic, some of our healthcare organizations estimated 1,800 duplicate records were being created every 24 hours, so it is a fair bet that the numbers are even greater now as people flock to schedule vaccines. How does the growing volume of patient traffic challenge our healthcare systems?
How would a shift to standardized medical records, possibly even a universal patient ID number, help healthcare systems and health outcomes?
What direction is the industry headed and what pain points are you solving for as you look to the future?
Summary: While approximately 25% of patients used patient portals prior to COVID-19, more than 235 million adults will likely interact with a patient portal or telehealth service for the first time. This new interaction sparks opportunity – an opportunity for patients to think differently about the role they are taking/playing in managing their health and an opportunity for healthcare organizations to think about how to build on and advance this newly formed relationship.
Karly Rowe is responsible for the Patient Access, Identity, and Care Management product portfolios at Experian Health. Leveraging her diverse background across credit, retail, and healthcare, Karly is responsible for finding new ways to leverage Experian’s data and analytical capabilities to develop new, innovative solutions for the healthcare industry.
Karly holds a Masters of Business Administration from Arizona State University and a Bachelor’s degree in Marketing Management and Retail Management from Syracuse University. She resides in Scottsdale, Arizona with her husband and two sons.
 
 
Website: experian.com/healthcare
Social Media Links: Twitter: twitter.com/Experian_Health Linkedin: linkedin.com/company/experian

Why should everyone consider getting the COVID vaccine?

 
 
Dr. Shirin Peters, Founder and Medical Director at Bethany Medical Clinic of New York, a primary care clinic network in New York City that provides primary and preventative care for busy New Yorkers at 8 clinic locations joins eHealth Radio and the Health News Channel.
Listen to interview with host Eric Michaels & guest Dr. Shirin Peters discuss the following:
What is in the COVID vaccine?
How was the COVID vaccine developed, tested and mass produced in such a short time?
Can you get COVID from the COVID vaccine?
What did the Pfizer and Moderna clinical trials for the COVID vaccine show?
If I had COVID already, should I still get the COVID vaccine?
Dr. Shirin Peters a physician, and entrepreneur with 10 years experience in the business of outpatients medicine. She is well versed in standard of care for Primary Care medicine as well as the world of medical billing and health insurance. She considers herself an expert in creating care models that delight patients and meet their individual needs, as well as in managing healthcare providers and keeping them engaged and able to practice at their best.
 
 
Website: www.bmcofny.com
Social Media Links: Instagram: @bethanymedicalofny | @drshirinpetersTwitter: @drshirinpeters Linkedin: linkedin.com/in/shirin-peters

How kindness can be a competitive edge in medical care

 
 
Dr. Larry Benz, the Co-Founder of Confluent Health, a network of physical therapy and occupational healthcare companies, and author of the best-selling book Called to Care: A Medical Provider’s Guide for Humanizing Healthcare joins eHealth Radio and the Health Care and Health News Channels.
Listen to interview with host Eric Michaels and guest Dr. Larry Benz discuss the following:
The pandemic has shed light on some major challenges medical providers are facing. Outside of our current, tragic circumstances, what are some of the biggest challenges you’ve seen in the industry?
In your book, you posit that kindness can be a competitive edge for healthcare providers. Can you explain what you mean?
You cite a remarkable study that showed during 25% of visits, doctors don’t even ask patients what is bothering them. What is your best advice for patients who find themselves in an appointment like that?
With the popularity of tele-health options increasing during COVID, what are some tips for how practitioners can emphasize care and connection with patients remotely?
You’ve done a lot of work studying the impact of positive psychology in medical care. Can you talk us through the application of positive psychology, and how it can impact patient outcomes?
Dr. Larry Benz, PT, DPT, OCS, MBA, MAPP, is the co-founder of Confluent Health, a network of physical therapy and occupational healthcare companies dedicated to educating and developing highly effective clinicians, strengthening private practice, reducing healthcare costs, and preserving care in healthcare.
A frequent lecturer at Physical Therapy programs, national conferences, and MBA schools throughout the country, Dr. Benz trained at Baylor University and the University of Pennsylvania. He is a nationally recognized award recipient for his expertise in private-practice Physical Therapy and occupational medicine.
As the co-developer of Jacmel Rehabilitation, Dr. Benz and his colleagues at Confluent Health and other various organizations have built a sustainable physical rehabilitation clinic in Haiti. For more information, please visit PThelpforHaiti.org and CalledtoCarebook.com.
 
 
Website: calledtocarebook.com
Social Media Links: Facebook: facebook.com/LarryBenz Instagram: instagram.com/physicaltherapist Linkedin: linkedin.com/in/lbenz

The importance of accurate and precise blood volume measurement in heart failure and critical care patients

 
Michael Feldschuh, the CEO of Daxor, an innovative medical instrumentation and biotechnology company focused on blood volume measurement joins eHealth Radio and the Health News and Technology Channels.
Listen to interview with host Eric Michaels and guest Michael Feldschuh discuss the following:
Can you tell me a bit about yourself and how you got interested in the medical technology field that led to your involvement with Daxor?
Let’s talk about BVA-100 and its benefits to physicians? How does BVA-100 differentiate from other similar technologies?
How does BVA-100 allow clinicians to provide better outcomes for their patients?
Are there any recent studies that validate BVA?
Please give us an overview of BVA-100 and how it improves outcomes for heart failure patients?
Daxor Corporation (NYSE: DXR) is an innovative medical instrumentation and biotechnology company focused on blood volume measurement. We developed and market the BVA-100® (Blood Volume Analyzer), the first diagnostic blood test cleared by the FDA to provide safe, accurate, objective quantification of blood volume status and composition compared to patient-specific norms. The BVA technology has the potential to improve hospital performance metrics in a broad range of surgical and medical conditions, including heart failure and critical care, by informing treatment strategies, resulting in significantly improved patient outcomes. Our mission is to partner with clinicians to incorporate BVA technology into standard clinical practice and improve the quality of life for patients.
 
 
Website: www.daxor.com
Social Media Links: Facebook: facebook.com/Daxorcorp  Linkedin: linkedin.com/company/daxorcorporation  Twitter: twitter.com/DaxorBVA